<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><description>Medical Oncologist, MD PhD I mother of two 👦👧|#BreastCancer immunotherapy investigator and scientist @JulesBordet Lecturer @ULBruxelles</description><link>https://bsky.app/profile/laubdh.bsky.social</link><title>@laubdh.bsky.social - Laurence Buisseret</title><item><link>https://bsky.app/profile/laubdh.bsky.social/post/3msvjnupfwc2a</link><description>Cancer du sein : le meilleur dépistage est celui auquel on participe https://www.lalibre.be/debats/opinions/2026/08/11/cancer-du-sein-le-meilleur-depistage-est-celui-auquel-on-participe-GH6SWHTXM5HRJAOFH3K66QLFSY/</description><pubDate>12 Aug 2026 16:16 +0000</pubDate><guid isPermaLink="false">at://did:plc:7znokoomnopskbqdzcynuwu4/app.bsky.feed.post/3msvjnupfwc2a</guid></item><item><link>https://bsky.app/profile/laubdh.bsky.social/post/3lpbhygdrds26</link><description>@hoperugo.bsky.social is discussing the results of the ROSALINE trial, an IIT sponsored by the Institut Jules Bordet that evaluated ROS1 inhibition with neo-adj endocrine therapy in early ILBC #ESMOBreast25 👏🏻 @aftimosp.bsky.social &amp; Soraia Lobo-Martins</description><pubDate>16 May 2025 07:11 +0000</pubDate><guid isPermaLink="false">at://did:plc:7znokoomnopskbqdzcynuwu4/app.bsky.feed.post/3lpbhygdrds26</guid></item><item><link>https://bsky.app/profile/laubdh.bsky.social/post/3lnsim5bxl22o</link><description>#AACR25 Cancer Research saves lives 🎗️</description><pubDate>27 Apr 2025 14:47 +0000</pubDate><guid isPermaLink="false">at://did:plc:7znokoomnopskbqdzcynuwu4/app.bsky.feed.post/3lnsim5bxl22o</guid></item><item><link>https://bsky.app/profile/laubdh.bsky.social/post/3lfb2bkiqms2w</link><description>&#xA;https://www.linkedin.com/posts/institut-jules-bordet_cancerdusein-oncologie-santaez-activity-7282722772911370241-2Er3?utm_source=share</description><pubDate>08 Jan 2025 20:53 +0000</pubDate><guid isPermaLink="false">at://did:plc:7znokoomnopskbqdzcynuwu4/app.bsky.feed.post/3lfb2bkiqms2w</guid></item><item><link>https://bsky.app/profile/laubdh.bsky.social/post/3ld4ivnqg7s2n</link><description>Excellent discussion by @marianabrandao0.bsky.social on treatment of patients with #NSCLC #ESMOImmuno24 Insightful perspectives on recent advances!</description><pubDate>12 Dec 2024 14:41 +0000</pubDate><guid isPermaLink="false">at://did:plc:7znokoomnopskbqdzcynuwu4/app.bsky.feed.post/3ld4ivnqg7s2n</guid></item><item><link>https://bsky.app/profile/laubdh.bsky.social/post/3lcvr5naixs2y</link><description>👏 to J. Stagg &amp; D. Allard for their work revealing ENT1 as a key driver of adenosine-mediated immunosuppression. This finding offers a promising new target to enhance T cell responses against tumors.&#xA;👉full study published in Cancer Research @theaacr.bsky.social &#xA;➡️ https://doi.org/10.1158/0008-5472.CAN-24-1875</description><pubDate>09 Dec 2024 22:20 +0000</pubDate><guid isPermaLink="false">at://did:plc:7znokoomnopskbqdzcynuwu4/app.bsky.feed.post/3lcvr5naixs2y</guid></item></channel></rss>